SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ACADIA Pharmaceuticals Inc (ACAD)
An SI Board Since April 2004
Posts SubjectMarks Bans Symbol
588 32 0 ACAD
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
138HIGH TROUGHPUT FUNCTIONAL ASSAY FOR G-PROTEIN COUPLED RECEPTORS USING A RAP-RAS scaram(o)uche-5/22/2005
137There was a news piece on Ambit from the San Diego Union-Tribune about a month asim1-5/17/2005
136>>ACADIA Pharmaceuticals Expands Technology Platform to Target Tyrosine Kituck-5/17/2005
135Scandinavia? Where - and what - is the "scandinavia" facility? It isSteve Lokness-5/17/2005
134ACADIA Pharmaceuticals Expands Technology Platform to Target Tyrosine Kinase Linsim1-5/17/2005
133S1 filed: SELLING STOCKHOLDERS On April 15, 2005, we entered into a securitmopgcw-5/10/2005
132ACADIA Pharmaceuticals Announces Election of Mary Ann Gray, Ph.D. to Board of Dimopgcw-4/28/2005
131Right. It was funny to see folks on the YMB post this stuff as if they were opetuck-4/26/2005
130Acadia Pharmaceuticals Inc.: SEC documents showed Director Carl Gordon purchasedmopgcw-4/26/2005
129Well BVF is nice to see as a tight wad value buyer. But I can't recall Bakerrkrw-4/20/2005
128Sheesh. Those guys/gals could have afforded top dollar. :-) Thanks for the discaram(o)uche-4/20/2005
127<pre>SCHEDULE OF PURCHASERS Purchaser ------------------------------keokalani'nui-4/20/2005
126ACADIA Pharmaceuticals Announces $36 Million Financing Friday April 15, 10:25 amnigel bates-4/19/2005
125TREATING NEUROPATHIC PAIN WITH NEUROPEPTIDE FF RECEPTOR 2 AGONISTS Patent numbescaram(o)uche-4/17/2005
124Yeah, and it only cost them 351 shares Monday and 29 on Wednesday to establish tscaram(o)uche-4/15/2005
123I want to know who invested. Big market opps for a such a small market cap.rkrw-4/15/2005
122that was quietly done!?mopgcw-4/15/2005
121ACADIA Pharmaceuticals Announces $36 Million Financing Friday April 15, 10:25 amscaram(o)uche-4/15/2005
120ACADIA Pharmaceuticals to Present at the Future Leaders in the Biotech Industry sim1-3/31/2005
119NEJM review of serotonin syndrome suggests substantial contributor to condition keokalani'nui-3/21/2005
118could be, either way it is not clear communication. alas.mopgcw-3/18/2005
117guess they could mean "stage of devp't" for the "program"scaram(o)uche-3/18/2005
116Late last year they filed the IND for agn-xx; had not heard from them since.mopgcw-3/18/2005
115Drug Discovery Opportunities Our proprietary drug discovery platform has genscaram(o)uche-3/18/2005
114Our Preclinical Discovery Programs In addition to our five development progrscaram(o)uche-3/18/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News